2seventy bio, Inc. (NASDAQ:TSVT) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the 2seventy bio Third Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
2Seventy Bio Inc. (TSVT)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Glazer Capital Paul Glazer | 0 | $0 | 0% | |
| 2. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 3. | Casdin Capital Eli Casdin | 0 | $0 | 0% | |
| 4. | AQR Capital Management Cliff Asness | 0 | $0 | 0% | |
| 5. | GLG Partners Noam Gottesman | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.10 | 40,000 | $203,992.00 | 2,000,000 | 2024-03-26 | Filing | |
| $5.07 | 330,000 | $1,673,991.00 | 1,960,000 | 2024-03-25 | Filing | |
| $5.12 | 147,377 | $754,069.16 | 1,630,000 | 2024-03-22 | Filing | |
| $4.90 | 300,000 | $1,470,990.00 | 1,482,623 | 2024-03-21 | Filing | |
| $5.96 | 86,414 | $515,027.44 | 5,142,111 | 2023-08-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.95 | 2,298 | $11,363.61 | 254,193 | 2025-03-17 | Filing | |
| $4.95 | 5,092 | $25,179.94 | 1,121,034 | 2025-03-17 | Filing | |
| $4.95 | 2,592 | $12,817.44 | 444,387 | 2025-03-17 | Filing | |
| $4.93 | 5,142,111 | $25,350,607.23 | 0 | 2025-03-11 | Filing | |
| $4.93 | 5,142,111 | $25,350,607.23 | 0 | 2025-03-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 93,115 | $465,575 | 0% | |
| 2. | 2,857 | $42,412 | 0% | |
| 3. | 0 | $75 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
2seventy bio, Inc. (NASDAQ:TSVT) Q2 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the 2Seventy Bio Second Quarter 2024 Earnings Conference Call.
5 Penny Stocks with Insider Buying in 2024
Biotech company 2Seventy Bio Inc (NASDAQ:TSVT) saw heavy insider buying activity earlier this year when Casdin Capital, LLC, which has a director status at 2Seventy Bio Inc (NASDAQ:TSVT), bought 777...
2seventy bio, Inc. (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript
2seventy bio, Inc. misses on earnings expectations. Reported EPS is $-0.81 EPS, expectations were $-0.72.
2seventy bio, Inc. (NASDAQ:TSVT) Q4 2023 Earnings Call Transcript
2seventy bio, Inc. beats earnings expectations. Reported EPS is $-1.11, expectations were $-1.22.
10 Stocks That Are About To Explode
The stock market has been quite tumultuous recently.
5 Oversold Small Cap Stocks To Buy
In this piece, we will take a look at the five oversold small cap stocks to buy.